Search results for "fusions"

showing 10 items of 176 documents

Isosorbide dinitrate: pharmacokinetics after intravenous administration.

1982

Isosorbide dinitrate (ISDN) is an important organic nitrate found therapeutically useful in its sublingual and oral forms in various cardiovascular diseases such as angina pectoris (1) and congestive heart failure (2). Recently Distante et al. (3) showed that an intravenous infusion of this drug, at 0.021–0.083 mg/min is also effective in managing unstable angina. The availability of an intravenous dosage form of ISDN not only affords the opportunity to characterize the pharmacokinetics of this drug after this particular mode of therapy, but also gives the possibility of assessing the bio-availability of this drug after other (e.g., oral) routes of administration in patients. This latter po…

DrugUnstable anginabusiness.industrymedia_common.quotation_subjectPharmaceutical ScienceIsosorbide Dinitratemedicine.diseaseDosage formAngina PectorisAnginaKineticsPharmacokineticsHeart failureAnesthesiamedicineHumansIn patientInfusions ParenteralIsosorbide dinitratebusinessmedia_commonmedicine.drugJournal of pharmaceutical sciences
researchProduct

Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.

2018

Objectives The implementation of dose-banding (DB) in centralised, pharmacy-based cytotoxic drug preparation units allows the preparation of standardised doses in series. The aim of this study was to evaluate the feasibility of DB for the prescribing of ganciclovir (GV) infusion solutions and to investigate the microbiological stability of dose-banded, automatically prepared ready-to-administer GV infusion bags by media-fill simulation tests and sterility tests. Methods The frequency of prescription of GV doses was retrospectively analysed before and after implementing the DB scheme. Four dose-ranges or ‘bands’ and the corresponding standard doses (250, 300, 350, 400 mg) were identified. Th…

GanciclovirCytotoxic drugSterilityDrug CompoundingDrug StorageGrowth promotion030226 pharmacology & pharmacyAntiviral AgentsStandard PreparationsExtended storage03 medical and health sciences0302 clinical medicineAnimal scienceDrug StabilityRefrigerationMedicineInfusions Parenteral030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsGanciclovirDrug PackagingRetrospective StudiesOriginal Researchbusiness.industryReproducibility of ResultsRoboticsRobotic systemsAseptic processingbusinessDrug ContaminationPharmacy Service Hospitalmedicine.drugEuropean journal of hospital pharmacy : science and practice
researchProduct

Assessment of the bioactivity of creosote-contaminated sediment by liver biotransformation system of rainbow trout.

1999

A sediment site in the Lake Jamsanvesi (municipality of Petajavesi, Finland) contaminated by creosote was investigated to assess the possible ecotoxicological risks it may cause to benthic animals, including ones which may arise due to physical measures in remediating the site. It is suggested that polycyclic aromatic hydrocarbons (PAHs) are bioavailable to fish and other aquatic animals during exposure to contaminated water, sediment, and food. In order to assess toxicological risks of sediment contents to fish, juvenile rainbow trout (Onchorhynchus mykiss) were intraperitoneally dosed with extracts of the creosote-contaminated sediments and their elutriates. This was compared to pristine …

Geologic SedimentsHealth Toxicology and MutagenesisBiological Availabilitylaw.inventionchemistry.chemical_compoundlawCytochrome P-450 CYP1A1AnimalsInfusions ParenteralWater pollutionSalmonidaeCreosotebiologyPublic Health Environmental and Occupational HealthSedimentAquatic animalGeneral Medicinebiology.organism_classificationPollutionTroutCreosotechemistryEnvironmental chemistryOncorhynchus mykissPyreneRainbow troutBiomarkersWater Pollutants ChemicalEcotoxicology and environmental safety
researchProduct

Multidisciplinary management of Hunter syndrome.

2009

Hunter syndrome is a rare, X-linked disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase. In the absence of sufficient enzyme activity, glycosaminoglycans accumulate in the lysosomes of many tissues and organs and contribute to the multisystem, progressive pathologies seen in Hunter syndrome. The nervous, cardiovascular, respiratory, and musculoskeletal systems can be involved in individuals with Hunter syndrome. Although the management of some clinical problems associated with the disease may seem routine, the management is typically complex and requires the physician to be aware of the special issues surrounding the patient with Hunter syndrome, and a multidiscipl…

GerontologyAdultMalemedicine.medical_specialtyAdolescentGenotypeIdursulfaseDiseaseIduronate SulfataseYoung AdultInternal medicineAnesthesiologymedicineHumansEnzyme Replacement TherapyCooperative BehaviorIntensive care medicineChildInfusions IntravenousMucopolysaccharidosis IIRandomized Controlled Trials as TopicPatient Care Teambusiness.industryHematopoietic Stem Cell TransplantationInfant NewbornInfantHunter syndromeEnzyme replacement therapymedicine.diseaseCombined Modality TherapyRecombinant ProteinsPulmonologyPhenotypeOtorhinolaryngologyChild PreschoolPediatrics Perinatology and Child HealthInterdisciplinary CommunicationNeurosurgerybusinessmedicine.drugPediatrics
researchProduct

Tumour-growth inhibition by induced hyperglycaemia/hyperlactacidaemia and localized hyperthermia.

1996

The present study was undertaken to exploit pathophysiological properties of solid tumours for a tumour-specific therapy. Experiments were carried out on DS-sarcomas implanted s.c. in the hind foot dorsum of Sprague Dawley rats. Treatment strategies included tumour acidification, lactate accumulation and disturbance of the microcirculation by induced systemic hyperglycaemia/hyperlact-acidaemia (15-25/10 mmol/L; for 60 min) as well as localized hyperthermia (water-bath; 43 degrees C, 30 min.). A special infusion solution was developed for the systemic treatment containing glucose, lactic acid and organic buffer without inorganic ions. Growth kinetics of tumour volume and animal survival were…

HyperthermiaCancer Researchmedicine.medical_specialtyPhysiologyCarbohydrate metabolismPharmacologyMicrocirculationRats Sprague-Dawleychemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineCombined Modality TherapyAnimalsHumansLactic AcidInfusions Intravenousbusiness.industryHyperthermia Inducedmedicine.diseaseCombined Modality TherapyPathophysiologyRatsEndocrinologyGlucosechemistryExperimental pathologySarcomaSarcoma ExperimentalGrowth inhibitionbusinessCell DivisionInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
researchProduct

High dose infusion of activated protein C (rhAPC) fails to improve neuronal damage and cognitive deficit after global cerebral ischemia in rats

2013

Abstract Purpose : Recent studies demonstrated anticoagulatory, antiinflammatory, antiapoptotic, and neuroprotective properties of activated protein C (APC) in rodent models of acute neurodegenerative diseases, suggesting APC as promising broad acting therapeutic agent. Unfortunately, continuous infusion of recombinant human APC (rhAPC) failed to improve brain damage following cardiac arrest in rats. The present study was designed to investigate the neuroprotective effect after global cerebral ischemia (GI) with an optimized infusion protocol. Methods : Rats were subjected to bilateral clip occlusion of the common carotid arteries (BCAO) and controlled hemorrhagic hypotension to 40 mmHg for…

IschemiaInflammationBrain damagePharmacologyNeuroprotectionBrain IschemiaRats Sprague-DawleyBrain ischemiamedicineAnimalsHumansCerebral perfusion pressureInfusions IntravenousCell Deathbusiness.industryGeneral NeuroscienceDrotrecogin alfaBrainmedicine.diseaseRecombinant ProteinsRatsAnesthesiamedicine.symptombusinessProtein CProtein Cmedicine.drugNeuroscience Letters
researchProduct

Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo.

2005

AbstractAngiotensin-II (Ang-II) has inflammatory activity and is involved in different diseases associated with the cardiovascular system. This study has evaluated the effect of boldine (B), and two phenanthrene alkaloids semisynthesized by us, secoboldine (SB) and boldine methine (BM), on Ang-II-induced neutrophil recruitment. Intraperitoneal administration of 1 nM Ang-II induced significant neutrophil accumulation, which was maximal at 4–8 h. BM inhibited neutrophil infiltration into the peritoneal cavity at 4 h and 8 h by 73% and 77%, respectively, SB at 8 h by 55%, and B had no effect on this response. Although BM inhibited the release of cytokine-inducible neutrophil chemoattractant/ke…

KeratinocytesMaleChemokineAporphinesEndotheliumNeutrophilsImmunologyChemokine CXCL2InflammationPharmacologyRats Sprague-Dawleychemistry.chemical_compoundIn vivomedicineImmunology and AllergyBoldineAnimalsHumansInfusions ParenteralPlatelet Activating FactorReceptorchemistry.chemical_classificationReactive oxygen speciesbiologyMolecular StructureAngiotensin IIMonokinesInterleukin-8Endothelial CellsCell BiologyPhenanthrenesAngiotensin IIRatsP-Selectinmedicine.anatomical_structureBiochemistrychemistrybiology.proteinIntercellular Signaling Peptides and Proteinsmedicine.symptomChemokinesReactive Oxygen SpeciesChemokines CXCJournal of leukocyte biology
researchProduct

Regional hypothermia of the kidney: surface or transarterial perfusion cooling? A functional study.

1980

Hypothermia reduces ischemic damage if prolonged occlusion of the renal artery is required during an in situ kidney operation. Hypothermia may be achieved by external cooling or by transarterial hypothermic perfusion. External cooling may lower intrarenal temperature heterogeneously. Perfusion techniques via intra-arterial catheters introduced percutaneously are associated with minimal technical difficulties. The 95 patients who underwent extensive hypothermic nephrolithotomy had differential 131iodine hippuran clearance studies preoperatively, and 2 weeks and 6 to 46 months postoperatively. Sixty-three kidneys were cooled by transarterial hypothermic perfusion and 39 were cooled with topic…

Kidneymedicine.medical_specialtyPercutaneousbusiness.industryUrologyRenal functionHypothermic perfusionHypothermiaKidneyRenal Artery ObstructionSurgeryKidney Calculimedicine.anatomical_structureHypothermia InducedAnesthesiamedicine.arteryOcclusionmedicineHumansInfusions Intra-Arterialmedicine.symptomRenal arterybusinessPerfusionThe Journal of urology
researchProduct

Efficacy of intra-arterial lidocaine infusion in the treatment of cerulein-induced acute pancreatitis

2020

Background Disturbances in pancreatic microcirculation, beginning with vasoconstriction, are crucial in early pancreatitis and progression to necrotizing pancreatitis. Thus, vascular-targeted treatment aiming to restore a sufficient level of microcirculation through vasodilation would possibly reduce the severity of pancreatitis. Lidocaine is an anti-arrhythmic and local anesthetic drug, which also acts as a vasodilator at higher concentrations. Objectives To evaluate the efficacy of intra-arterial infusion of lidocaine into the celiac trunk in treatment of cerulein-induced acute pancreatitis. Material and methods Wistar rats (n = 20) were randomly divided into 2 equal groups: the control g…

Lidocaineacute pancreatitismedicine.drug_classMedicine (miscellaneous)microcirculationVasodilationLidocaine HydrochlorideGeneral Biochemistry Genetics and Molecular BiologyMicrocirculationRandom Allocationregional arterial infusionInternal MedicineMedicineAnimalsInfusions Intra-ArterialPharmacology (medical)Rats WistarPancreasGenetics (clinical)business.industryLocal anestheticmedicine.diseaseRatsTreatment OutcomePancreatitisAnesthesiaReviews and References (medical)Acute DiseaselidocainePancreatitisAcute pancreatitismedicine.symptombusinessVasoconstrictionCeruletidemedicine.drugAdvances in Clinical and Experimental Medicine
researchProduct

Involvement of neuronal processes and nitric oxide in the inhibition by endotoxin of pentagastrin-stimulated sastric acid secretion

1994

Administration of E. coli endotoxin (1 mg kg-1, i.v.) abolished the acid response induced by the i.v. infusion of pentagastrin (8 micrograms kg-1 h-1) in the continuously perfused stomach of the anaesthetized rat. Local serosal application of tetrodotoxin (36 ng per rat) completely restored acid responses to pentagastrin in endotoxin-treated rats. However, pretreatment with atropine (0.5 mg kg-1, s.c.), capsaicin (20, 30, and 50 mg kg-1, s.c. 2 weeks before the study) or guanethidine (16 mg kg-1, s.c. 3 and 16h before) did not influence the inhibitory effects of endotoxin. Continuous i.v. infusion with NG-nitro arginine methyl ester (L-NAME, 10 mg kg-1 h-1) restored the secretory responses …

LipopolysaccharidesMalemedicine.medical_specialtyTetrodotoxinPeptide hormoneBiologyArginineNitric OxideNitric oxideGastric AcidPhenylephrinechemistry.chemical_compoundInternal medicineEscherichia colimedicineAnimalsDrug InteractionsRats WistarInfusions IntravenousGuanethidineNeuronsPharmacologyStomachGeneral MedicineRatsEndotoxinsPentagastrinNG-Nitroarginine Methyl EsterEndocrinologyMechanism of actionchemistryGastrointestinal hormoneGastric MucosaCapsaicinTetrodotoxinFemalePentagastrinmedicine.symptommedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct